AbbVie Moves Allergan Profits to U.S. in Partial GOP Tax Law Win
- Allergan could owe some U.S. tax, but remains an Irish company
- Stricter U.S. tax laws have largely stopped corporate exits
This article is for subscribers only.
Allergan Plc, the drugmaker that emigrated to Ireland to avoid U.S. taxes in 2015, is now coming home -- at least partially.
Allergan’s income will generate some U.S. taxes because of a deal announced Tuesday for AbbVie Inc. to acquire the Dublin-based company, even though it will remain in Ireland.